LLY
800.77
-0.47%↓
UNH
537.55
-0.92%↓
JNJ
151.14
+0.33%↑
ABBV
175.17
+0.23%↑
NVO
83.98
-1.12%↓
LLY
800.77
-0.47%↓
UNH
537.55
-0.92%↓
JNJ
151.14
+0.33%↑
ABBV
175.17
+0.23%↑
NVO
83.98
-1.12%↓
LLY
800.77
-0.47%↓
UNH
537.55
-0.92%↓
JNJ
151.14
+0.33%↑
ABBV
175.17
+0.23%↑
NVO
83.98
-1.12%↓
LLY
800.77
-0.47%↓
UNH
537.55
-0.92%↓
JNJ
151.14
+0.33%↑
ABBV
175.17
+0.23%↑
NVO
83.98
-1.12%↓
LLY
800.77
-0.47%↓
UNH
537.55
-0.92%↓
JNJ
151.14
+0.33%↑
ABBV
175.17
+0.23%↑
NVO
83.98
-1.12%↓
24h
Current
Min
19.74
Max
20.61
Recommendations | Buy |
---|---|
12 Months Forecast | +109.04 upside |
Next Earnings | 10 Feb 2025 |
---|
By Acuity
53%
47%
327 / 393 Healthcare
By Trading Central
Confidence
Very Strong Bullish Evidence
18.325 / 19.71 Support & Resistance
Past performance is not a reliable indicator of future results.
3 Sept 2024, 10:38 UTC
Arrowhead Pharmaceuticals Shares Climb on Plans to File New Drug Application for Plozasiran
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 42.33 USD 109.04%
High 80 USD
Low 24 USD
Based on 10 Wall Street analysts offering 12 month price targets forArrowhead Pharmaceuticals Inc - Dist in the last 3 months.
By TipRanks
Buy
10 ratings
6
Buy
4
Hold
0
Sell
Based on 10 analysts giving stock ratings to Arrowhead Pharmaceuticals Inc - Dist in the past 3 months.
By Trading Central
Short Term
Very Strong Bullish Evidence
Bullish events outweigh bearish events.
Intermediate Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Strong Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
$